Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Phase III trial of an alpha-pharmaceutical

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.09.11
Views: 3790
Rating:

Dr Chris Parker - The Royal Marsden Cancer Centre, London, UK

During a press conference at EMCC 2011 in Stockhol, Dr Parker gave a presentation on the first Phase III trial of an alpha-pharmaceutical shows improved survival in patients with bone metastases and advanced prostate cancer

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation